| abstract |
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun N-terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the prevention and/or treatment of Mild Cognitive Impairment, in particular of Mild Cognitive Impairment due to Alzheimer's Disease. |